Type i interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice

Gastroenterology

Volumn 143, Issue 1, 2012, Pages 145-154

  Lee, Shee Eun ^a,b   Li, Xiangli ^a   Kim, Joanna C K ^a   Lee, Jongdae ^a   González Navajas, Jose M ^a,c   Hong, Seol Hee ^b   Park, In Kyu ^b   Rhee, Joon Haeng ^b   Raz, Eyal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chonnam National University   (South Korea)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adoptive Transfer; Immune Regulation; Inflammatory Bowel Disease; Mouse Model

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; INTERFERON; PEGINTERFERON ALPHA2A; RAG1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TYPE 1 INTERFERON; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLITIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84862740015     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.03.042     Document Type: Article

References (40)

1. A. Izcue, J.L. Coombes, F. Powrie Regulatory lymphocytes and intestinal inflammation Annu Rev Immunol 27 2009 313 338
2. R.J. Xavier, D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
3. L.A. Zenewicz, A. Antov, R.A. Flavell CD4 T-cell differentiation and inflammatory bowel disease Trends Mol Med 15 2009 199 207
4. A. Izcue, J.L. Coombes, F. Powrie Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation Immunol Rev 212 2006 256 271
5. F. Powrie, M.W. Leach, S. Mauze Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C B-17 scid mice Int Immunol 5 1993 1461 1471
6. Y. Belkaid, K. Tarbell Regulatory T cells in the control of host-microorganism interactions (*) Annu Rev Immunol 27 2009 551 589
7. S. Sakaguchi, T. Yamaguchi, T. Nomura Regulatory T cells and immune tolerance Cell 133 2008 775 787
8. S. Hori Developmental plasticity of Foxp3+ regulatory T cells Curr Opin Immunol 22 2010 575 582
9. M.E. Brunkow, E.W. Jeffery, K.A. Hjerrild Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat Genet 27 2001 68 73
10. C.L. Bennett, J. Christie, F. Ramsdell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
11. S.Z. Josefowicz, A. Rudensky Control of regulatory T cell lineage commitment and maintenance Immunity 30 2009 616 625
12. G. Oldenhove, N. Bouladoux, E.A. Wohlfert Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection Immunity 31 2009 772 786
13. X. Zhou, S. Bailey-Bucktrout, L.T. Jeker Plasticity of CD4(+) FoxP3(+) T cells Curr Opin Immunol 21 2009 281 285
14. J.M. Gonzalez-Navajas, J. Lee, M. David Immunomodulatory functions of type I interferons Nat Rev Immunol 12 2012 125 135
15. K. Katakura, J. Lee, D. Rachmilewitz Toll-like receptor 9-induced type I IFN protects mice from experimental colitis J Clin Invest 115 2005 695 702
16. J.M. Gonzalez-Navajas, J. Law, K.P. Nguyen Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production J Exp Med 207 2010 2799 2807
17. B. Guo, E.Y. Chang, G. Cheng The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice J Clin Invest 118 2008 1680 1690
18. M.L. Shinohara, J.H. Kim, V.A. Garcia Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin Immunity 29 2008 68 78
19. J. Lee, J.H. Mo, K. Katakura Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells Nat Cell Biol 8 2006 1327 1336
20. J.M. Gonzalez-Navajas, S. Fine, J. Law TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice J Clin Invest 120 2010 570 581
21. D. Mucida, Y. Park, G. Kim Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid Science 317 2007 256 260
22. B. Weigmann, I. Tubbe, D. Seidel Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue Nat Protoc 2 2007 2307 2311
23. L.W. Collison, C.J. Workman, T.T. Kuo The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 450 2007 566 569
24. S. Deaglio, K.M. Dwyer, W. Gao Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J Exp Med 204 2007 1257 1265
25. A. Kaser, R.S. Blumberg Adaptive immunity in inflammatory bowel disease: state of the art Curr Opin Gastroenterol 24 2008 455 461
26. S. Sakaguchi, N. Sakaguchi, M. Asano Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
27. K. Wing, Y. Onishi, P. Prieto-Martin CTLA-4 control over Foxp3+ regulatory T cell function Science 322 2008 271 275
28. Y. Zheng, S.Z. Josefowicz, A. Kas Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells Nature 445 2007 936 940
29. S. Videla, A. Lugea, J. Vilaseca Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats Int J Colorectal Dis 22 2007 571 580
30. K.S. Bergstrom, V. Kissoon-Singh, D.L. Gibson Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa PLoS Pathog 6 2010 e1000902
31. T. Yamaguchi, J.B. Wing, S. Sakaguchi Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions Semin Immunol 23 2011 424 430
32. J. Koreth, K. Matsuoka, H.T. Kim Interleukin-2 and regulatory T cells in graft-vs-host disease N Engl J Med 365 2011 2055 2066
33. H. Qiu, Y. Fan, A.G. Joyee Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages J Immunol 181 2008 2092 2102
34. A.A. Vandenbark, J. Huan, M. Agotsch Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis J Neuroimmunol 215 2009 125 128
35. R. Kuhn, J. Lohler, D. Rennick Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
36. S.C. Kim, S.L. Tonkonogy, C.A. Albright Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria Gastroenterology 128 2005 891 906
37. S.M. Madsen, P. Schlichting, B. Davidsen An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis Am J Gastroenterol 96 2001 1807 1815
38. S. Nikolaus, P. Rutgeerts, R. Fedorak Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study Gut 52 2003 1286 1290
39. H. Tilg, H. Vogelsang, O. Ludwiczek A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis Gut 52 2003 1728 1733
40. P.J. Mannon, R.L. Hornung, Z. Yang Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production Gut 60 2011 449 455